ScienceEU-Startupsabout 4 hours ago
Bionyra Pharma launches with €143 million Series A
4 min read
Bionyra Pharma launched with a €143 million oversubscribed Series A round co-led by Jeito Capital and Sofinnova Partners. The clinical-stage biopharma company develops next-generation biologics for immune-mediated inflammatory diseases. Sanofi Ventures and other investors also participated in the financing.
Level
Hype check
Tap to vote and see what everyone thinks.
